Matches in Nanopublications for { ?s ?p "[Cancer cells require nutrients and energy to adapt to increased biosynthetic activity, and protein synthesis inhibition downstream of mammalian target of rapamycin complex 1 (mTORC1) has shown promise as a possible therapy for acute myeloid leukemia (AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- assertion description "[Cancer cells require nutrients and energy to adapt to increased biosynthetic activity, and protein synthesis inhibition downstream of mammalian target of rapamycin complex 1 (mTORC1) has shown promise as a possible therapy for acute myeloid leukemia (AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP504948.RAxKdf_SY8cA23OY1CTmlH3R4l2_OqnzU__yGbSlz1vKI130_assertion description "[Cancer cells require nutrients and energy to adapt to increased biosynthetic activity, and protein synthesis inhibition downstream of mammalian target of rapamycin complex 1 (mTORC1) has shown promise as a possible therapy for acute myeloid leukemia (AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP504948.RAxKdf_SY8cA23OY1CTmlH3R4l2_OqnzU__yGbSlz1vKI130_provenance.
- NP411874.RA82iX_5oHL5QFk1mSWTP39RCe6VHcEQfmAMkqnNkyp4A130_assertion description "[Cancer cells require nutrients and energy to adapt to increased biosynthetic activity, and protein synthesis inhibition downstream of mammalian target of rapamycin complex 1 (mTORC1) has shown promise as a possible therapy for acute myeloid leukemia (AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP411874.RA82iX_5oHL5QFk1mSWTP39RCe6VHcEQfmAMkqnNkyp4A130_provenance.
- NP1108547.RAPJ12j28Pn1ueZORAMB-hloorbR-qrBRHEAo6zhNW6jU130_assertion description "[Cancer cells require nutrients and energy to adapt to increased biosynthetic activity, and protein synthesis inhibition downstream of mammalian target of rapamycin complex 1 (mTORC1) has shown promise as a possible therapy for acute myeloid leukemia (AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1108547.RAPJ12j28Pn1ueZORAMB-hloorbR-qrBRHEAo6zhNW6jU130_provenance.